LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdo
Go back to LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdo| (NASDAQ: LENZ) | Delayed: 6.77 +0.27 (4.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.50 | 52 Week High | $ | |||
| Open | $6.48 | 52 Week Low | $ | |||
| Day High | $6.87 | P/E | N/A | |||
| Day Low | $6.48 | EPS | $ | |||
| Volume | 283,715 | |||||
